Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials

SHANGHAI, June 22, 2022 /PRNewswire/ — Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing. The funds will be used to commercialize its Viridimin™ brand…